# CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).

> **NCT05797792** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Hospital Clinic of Barcelona** · enrollment: 440 (estimated)

## Conditions studied

- Stroke, Acute Ischemic
- Stroke, Acute

## Interventions

- **DRUG:** Intraarterial alteplase

## Key facts

- **NCT ID:** NCT05797792
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-18
- **Primary completion:** 2025-08-26
- **Final completion:** 2025-11-14
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05797792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05797792, "CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05797792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*